Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Revisiting Race and the Benefit of RAS Blockade in Heart Failure
Li Shen, Matthew M.Y. Lee, Pardeep S. Jhund, Christopher B. Granger, Inder S. Anand, Aldo Maggioni, Marc A. Pfeffer, Scott D. Solomon, Karl Swedberg, Salim Yusuf, John J.V. McMurray (2024). Revisiting Race and the Benefit of RAS Blockade in Heart Failure. , 331(24), DOI: https://doi.org/10.1001/jama.2024.6774.
Article14 days agoAbstract 4365699: Liver fibrosis as assessed by the fibrosis-5 (FIB-5) index in patients with heart failure: Insights from the PARADIGM-HF and PARAGON-HF trials
Daniel Pham, Mingming Yang, Arzu Kalaycı, Alan Henderson, Inder S. Anand, Akshay S. Desai, Aldo Maggioni, Felipe A. Martínez, Marc A. Pfeffer, Jean L. Rouleau, Karl Swedberg, Muthiah Vaduganathan, Dirk van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Adel R. Rizkala, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray (2025). Abstract 4365699: Liver fibrosis as assessed by the fibrosis-5 (FIB-5) index in patients with heart failure: Insights from the PARADIGM-HF and PARAGON-HF trials. , 152(Suppl_3), DOI: https://doi.org/10.1161/circ.152.suppl_3.4365699.
Article14 days agoPO-07-199 IDENTIFYING POTENTIAL ICD CANDIDATES IN 16,550 PATIENTS WITH EF ≤ 55% WITH THE NOVEL SEATTLE PROPORTIONAL RISK MODEL FOR MILDLY REDUCED EF (SPRM-MR)
Wayne C. Levy, Neal A. Chatterjee, Todd Dardas, Christine M. Albert, Ramin Shadman, Marvin A. Konstam, Aldo Maggioni, Inder S. Anand, Faiez Zannad, Peter E. Carson, Gust H. Bardy, Kelley R. Branch, Jeanne E. Poole (2025). PO-07-199 IDENTIFYING POTENTIAL ICD CANDIDATES IN 16,550 PATIENTS WITH EF ≤ 55% WITH THE NOVEL SEATTLE PROPORTIONAL RISK MODEL FOR MILDLY REDUCED EF (SPRM-MR). , 22(4), DOI: https://doi.org/10.1016/j.hrthm.2025.03.1896.
Article14 days agoEffects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF
Toru Kondo, Pardeep S. Jhund, Inder S. Anand, Brian Claggett, Akshay S. Desai, Kieran F. Docherty, Carolyn Lam, Martin Lefkowitz, Aldo Maggioni, Felipe A. Martínez, Margaret M. Redfield, Jean L. Rouleau, Dirk Jan van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Scott Solomon, John J.V. McMurray (2025). Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF. , 13(6), DOI: https://doi.org/10.1016/j.jchf.2024.12.010.
Article14 days agoSacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair Henderson, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo Maggioni, Felipe A. Martínez, Jean L. Rouleau, Karl Swedberg, Muthiah Vaduganathan, Dirk J van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Adel R. Rizkala, Eldrin F. Lewis, Pardeep S. Jhund, Scott D Solomon, John J.V. McMurray (2025). Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF. , 11(7), DOI: https://doi.org/10.1093/ehjcvp/pvaf064.
Article14 days ago